GOVX Projected Dividend Yield
Com Par $0.0001 Aug 2020/GeoVax Labs Inc ( NASDAQ : GOVX )GeoVax Labs is a clinical-stage biotechnology company developing immunotherapies and vaccines against infectious diseases and solid tumor cancers using vector vaccine platforms. Co.'s product pipeline includes human clinical trials in COVID-19 vaccine and a theraphy against head and neck cancer. Additional research and development programs include preventive vaccines against Monkeypox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa) and Zika virus, as well as immunotherapies for multiple solid tumors. Co.'s cancer therapy programs are Gedeptin® and MUC1-based Immunotherapy. 20 YEAR PERFORMANCE RESULTS |
GOVX Dividend History Detail GOVX Dividend News GOVX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |